References
1. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011 Aug;58(10):1001–6.
2. Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J. 2017 Oct;38(40):2995–3005.
3. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, et al. Detection and management of an implantable cardioverter defibrillator lead failure: Incidence and clinical implications. J Am Coll Cardiol. 2003 Jan;41(1):73–80.
4. Wazni O, Wilkoff BL. Considerations for cardiac device lead extraction. Nat Rev Cardiol. 2016 Apr;13(4):221–9.
5. Bongiorni MG, Burri H, Deharo JC, Starck C, Kennergren C, Saghy L, et al. 2018 EHRA expert consensus statement on lead extraction: Recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: Endorsed by APHRS/HRS/LAHRS. Vol. 20, Europace. Oxford University Press; 2018. p. 1217-1217j.
6. Pelargonio G, Narducci M, Russo E, Casella M, Santangeli P, Canby R, et al. Safety and effectiveness of transvenous lead extraction in octogenarians. J Cardiovasc Electrophysiol. 2012 Oct;23(10):1103–8.
7. Diemberger I, Mazzotti A, Biffi M, Massaro G, Martignani C, Ziacchi M, et al. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices. 2013 Jul;10(4):551–73.
8. Zsigmond EJ, Miklos M, Vida A, Benak A, Makai A, Schvartz N, et al. Reimplantation and long-term mortality after transvenous lead extraction in a high-risk, single-center cohort. J Interv Card Electrophysiol. 2021 Mar;
9. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Hear Rhythm. 2010;7(8):1043–7.
10. Polewczyk A, Jacheć W, Tomaszewski A, Brzozowski W, Czajkowski M, Opolski G, et al. Lead-related infective endocarditis: Factors influencing early and long-term survival in patients undergoing transvenous lead extraction. Hear Rhythm. 2017 Jan;14(1):43–9.
11. Mehta VS, Elliott MK, Sidhu BS, Gould J, Kemp T, Vergani V, et al. Long-term survival following transvenous lead extraction: Importance of indication and comorbidities. Hear Rhythm. 2021 Sep;18(9):1566–76.
12. Maytin M, Jones SO, Epstein LM. Long-term mortality after transvenous lead extraction. Circ Arrhythmia Electrophysiol. 2012;5(2):252–7.
13. Hörnsten J, Axelsson L, Westling K. Cardiac Implantable Electronic Device Infections; Long-Term Outcome after Extraction and Antibiotic Treatment. Infect Dis Reports 2021, Vol 13, Pages 627-635. 2021 Jul;13(3):627–35.
14. Gomes S, Cranney G, Bennett M, Giles R. Long-Term Outcomes Following Transvenous Lead Extraction. Pacing Clin Electrophysiol. 2016 Apr;39(4):345–51.
15. Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: A prospective matched cohort study. Heart. 2012;98(9):724–31.
16. Clémenty N, Carion PL, de Léotoing L, Lamarsalle L, Wilquin-Bequet F, Brown B, et al. Infections and associated costs following cardiovascular implantable electronic device implantations: A nationwide cohort study. Europace. 2018;
17. Chronic kidney disease: assessment and management NICE guideline. 2021;
18. Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021 Apr;27(4):387–413.
19. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Nov;36(44):3075–123.
20. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, et al. Nonvalvular Cardiovascular Device-Related Infections. Circulation. 2003;108(16):2015–31.
21. Baman TS, Gupta SK, Valle JA, Yamada E. Risk Factors for Mortality in Patients With Cardiac Device-Related Infection. Circ Arrhythmia Electrophysiol. 2009 Apr;2(2):129–34.
22. Nishii N, Nishimoto T, Mizuno T, Masuda T, Asada S, Miyamoto M, et al. Prognosis of patients with severe left ventricular dysfunction after transvenous lead extraction and the need for additional hemodynamic support in the perioperative period. Hear Rhythm. 2021 Jun;18(6):962–9.